1.
|
Details of PDMR/person closely associated with them
('PCA')
|
||||
a)
|
Name
|
Lady Susan Symonds
|
|||
b)
|
Position/status
|
PCA of Sir Jonathan Symonds (Non-Executive Chair)
|
|||
c)
|
Initial notification/amendment
|
Initial notification
|
|||
2.
|
Details of the issuer, emission allowance market participant,
auction platform, auctioneer or auction monitor
|
||||
a)
|
Name
|
GSK plc
|
|||
b)
|
LEI
|
5493000HZTVUYLO1D793
|
|||
3.
|
Details of the transaction(s): section to be repeated for (i) each
type of instrument; (ii) each type of transaction; (iii) each date;
and (iv) each place where transaction(s) has been
conducted
|
||||
a)
|
Description of the financial instrument
|
Ordinary shares of 31 ¼ pence each ('Ordinary
Shares')
ISIN: GB00BN7SWP63
|
|||
b)
|
Nature of the transaction
|
Purchase of 7,150 Ordinary Shares
|
|||
c)
|
Price(s) and volume(s)
|
|
Price(s)
|
Volume(s)
|
|
|
£13.9365
|
7,150
|
|
||
|
|
|
|
||
d)
|
Aggregated information
Aggregated volume Price
|
N/A (single transaction)
|
|||
e)
|
Date of the transaction
|
2024-10-30
|
|||
f)
|
Place of the transaction
|
London Stock Exchange (XLON)
|
|
GSK plc
|
|
(Registrant)
|
|
|
Date: October
30, 2024
|
|
|
|
|
By:/s/ VICTORIA
WHYTE
--------------------------
|
|
|
|
Victoria Whyte
|
|
Authorised
Signatory for and on
|
|
behalf
of GSK plc
|